This page includes the latest FDA filings for Shorla Pharma L T D. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
Device Company | Device | Date |
---|---|---|
Shorla Oncology Inc., Shorla Pharma Ltd., AqVida GmbH | Prescription Medication | 2025-01-01 |
Shorla Oncology Inc.,, Shorla Pharma Ltd., L M Manufacturing Limited | Prescription Medication | 2024-12-20 |
SHORLA ONCOLOGY INC., SHORLA PHARMA LTD., SGS Quay Pharmaceuticals Limited | Prescription Medication | 2024-11-05 |
SHORLA ONCOLOGY INC., SHORLA PHARMA LTD., SGS Quay Pharmaceuticals Limited | Prescription Medication | 2023-12-15 |
Shorla Oncology Inc., Shorla Pharma Ltd., AqVida GmbH | Prescription Medication | 2023-03-15 |
NCAGE Code | SGKW2 | SHORLA PHARMA LIMITED |
CAGE Code | SGKW2 | SHORLA PHARMA LIMITED |
S.A.M. Registration | SGKW2 [985706879] | SHORLA PHARMA LIMITED |